Expression Therapeutics

Expression Therapeutics operates as a biotech firm situated in Atlanta. The company's therapeutic lineup encompasses state-of-the-art gene therapies targeting hemophilia A and B, neuroblastoma, T-cell leukemia/lymphoma, acute myeloid leukemia (AML), and hematologic conditions such as hemophagocytic lymphohistiocytosis (HLH). Each potential product has been meticulously engineered using exclusive gene expression biotechnologies to ensure maximum safety and effectiveness.